Finance

Beta
Lists
2652:HKG
CF PharmTech Inc
HK$18.12
+1.57%
(+0.28) 1D
Jun 12, 4:08:19 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2652...
Open
HK$17.83
High
HK$18.18
Low
HK$17.70
Mkt. cap
7.44B
Avg. vol.
585.62K
Volume
0.00
52-wk high
HK$48.80
52-wk low
HK$17.30
Shares outstanding
302.22M
No. of employees
540
Open
HK$17.83
High
HK$18.18
Low
HK$17.70
Mkt. cap
7.44B
Avg. vol.
585.62K
Volume
0.00
52-wk high
HK$48.80
52-wk low
HK$17.30
Shares outstanding
302.22M
No. of employees
540
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 2652 in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 2652 in the last 3 months.
Highest
Current HK$18.12
HK$38.22 (+110.93%)
Average
HK$38.22 (+110.93%)
Lowest
HK$38.22 (+110.93%)
News stories
From sources across the web
About CF PharmTech Inc
CEO-
Employees540
Founded2007
Headquarters-
SectorPharmaceutical industry
Websitecfpharmtech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Revenue
135.94M
Cost of goods sold
28.28M
Cost of revenue
28.28M
Research and development expenses
32.34M
Total research and development expenses
-
Selling, general, and admin expenses
65.66M
Operating expense
99.07M
Total operating expenses
127.34M
Operating income
8.60M
Other non operating income
1.63M
EBT including unusual items
11.43M
EBT excluding unusual items
9.75M
Income tax expense
-1.39M
Effective tax rate
-12.15%
Other operating expenses
-
Net income
12.82M
Net profit margin
9.43%
Earnings per share
-
Interest and investment income
91.00K
Interest expense
-567.00K
Net interest expenses
-476.00K
Depreciation and amortization charges
-
EBITDA
23.42M
Gain or loss from assets sale
23.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer